Other Corticosteroid Sparing or Anti-inflammatory Agents
Some therapeutic agents have been studied for their ability to suppress steroid-dependent asthmatic symptoms. While initial individual case reports and limited clinical trials offer some promise for these agents, their use for the treatment of asthma is still considered experimental, with the exception of Xolair® which is FDA approved. The Asthma Center specialists will consider use of these medications only after standard treatments fail to control symptoms and your asthma is very severe.
Examples include:
Hydroxychloroquine (Plaquenil®)
Methotrexate
Intravenous immunoglobulin (IVIg)
Oral gold therapy (Ridaura® [auranofin])
Cyclosporine
Omalizumab (Xolair®) gammaglobulin
Azathioprine
Dapsone
